Drug intelligence / Profile preview

Polinevrin

Development stage
Unknown
Lead developer
Valenta Pharm
Modality
Small Molecules
Administration
Oral
01

Overview

Polinevrin is a metabolic support product developed by Valenta Pharmaceuticals, primarily used for the management of peripheral neuropathies, including polyneuropathy. Although registered in Russia as a biologically active food additive (dietary supplement) rather than a traditional pharmaceutical drug, it is formulated to support the structural and functional recovery of the nervous system. The product contains uridine monophosphate, a key nucleotide that serves as a precursor for the synthesis of pyrimidine nucleotides and phospholipids required for the repair of neuronal membranes and myelin sheaths. By providing essential building blocks for nerve regeneration, Polinevrin aims to improve reflex reactions and alleviate symptoms associated with nerve damage.

Brand names
Polinevrin
Other names
Polinevrin-Valenta
02

Targets

CMPK1 (Deoxycytidylate kinase)

Beyond the preview

Go deeper on Polinevrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polinevrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call